HK1025055A1 - A pharmaceutical composition for treating dysmenorrhea and premature labor - Google Patents

A pharmaceutical composition for treating dysmenorrhea and premature labor

Info

Publication number
HK1025055A1
HK1025055A1 HK00104419A HK00104419A HK1025055A1 HK 1025055 A1 HK1025055 A1 HK 1025055A1 HK 00104419 A HK00104419 A HK 00104419A HK 00104419 A HK00104419 A HK 00104419A HK 1025055 A1 HK1025055 A1 HK 1025055A1
Authority
HK
Hong Kong
Prior art keywords
premature labor
pharmaceutical composition
composition
beta
treating dysmenorrhea
Prior art date
Application number
HK00104419A
Other languages
English (en)
Inventor
Howard L Levine
William J Bologna
Ziegler Dominique De
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26738031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1025055(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of HK1025055A1 publication Critical patent/HK1025055A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK00104419A 1997-09-12 2000-07-19 A pharmaceutical composition for treating dysmenorrhea and premature labor HK1025055A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5878997P 1997-09-12 1997-09-12
US09/145,172 US6126959A (en) 1997-09-12 1998-09-01 Pharmaceutical composition for treating dysmenorrhea and premature labor
PCT/US1998/018538 WO1999013862A2 (en) 1997-09-12 1998-09-08 A pharmaceutical composition for treating dysmenorrhea and premature labor

Publications (1)

Publication Number Publication Date
HK1025055A1 true HK1025055A1 (en) 2000-11-03

Family

ID=26738031

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00104419A HK1025055A1 (en) 1997-09-12 2000-07-19 A pharmaceutical composition for treating dysmenorrhea and premature labor

Country Status (20)

Country Link
US (2) US6126959A (de)
EP (1) EP1011632B1 (de)
JP (1) JP2002503637A (de)
KR (1) KR100575386B1 (de)
CN (1) CN1186009C (de)
AT (1) ATE253892T1 (de)
AU (1) AU738460B2 (de)
BR (1) BR9812134A (de)
CA (1) CA2303339C (de)
DE (1) DE69819748T2 (de)
DK (1) DK1011632T3 (de)
ES (1) ES2210813T3 (de)
HK (1) HK1025055A1 (de)
HU (1) HUP0003784A3 (de)
IL (1) IL134564A0 (de)
NO (1) NO329203B1 (de)
NZ (1) NZ502926A (de)
PT (1) PT1011632E (de)
RO (1) RO120814B1 (de)
WO (1) WO1999013862A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344732B2 (en) * 2002-01-10 2008-03-18 Kimberly-Clark Worldwide, Inc. Medicated tampon
US7341737B2 (en) * 1997-06-11 2008-03-11 Kimberly-Clark Worldwide, Inc. Medicated tampon
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
RU2310474C2 (ru) * 1999-10-05 2007-11-20 Колумбия Лабораториз (Бермуда) Лимитед Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
UA74168C2 (uk) * 1999-10-05 2005-11-15 Коламбіа Леборетеріс (Бермуда) Лімітед Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
FR2841223B1 (fr) 2002-06-19 2004-10-15 Sleever Int Enveloppe d'emballage d'objets(s) en materiau thermoretractable a face interne ou externe essentiellement lisse
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
AR041021A1 (es) 2002-08-22 2005-04-27 Novartis Consumer Health Sa Composicion topica
US20060165803A1 (en) * 2002-12-18 2006-07-27 Celia Palacin Pharmaceutical compositions of sertaconazole for vaginal use
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
WO2005027939A1 (en) * 2003-08-21 2005-03-31 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
CN101005830B (zh) * 2004-08-13 2010-09-29 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放片剂、其制备方法及用途
NZ553645A (en) * 2004-08-13 2010-09-30 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US7481815B2 (en) * 2004-09-23 2009-01-27 Synthes (U.S.A.) Coplanar X-ray guided aiming arm for locking of intramedullary nails
US7993667B2 (en) 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7919453B2 (en) 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US7744556B2 (en) 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7708726B2 (en) 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
JP2009526021A (ja) * 2006-02-10 2009-07-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 放出を加減した製剤
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
US8992589B2 (en) 2007-12-03 2015-03-31 The Florida State University Research Foundation, Inc. Using light to regulate uterine contractions
WO2009073184A1 (en) * 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions for inducing labor and associated methods
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
BRPI0803568B8 (pt) * 2008-08-14 2021-05-25 Biolab San Us Farm Ltda composição mucoaderente
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
GB2484977A (en) * 2010-10-29 2012-05-02 Biocopea Ltd Treatment of a Th-1 mediated disease
US8946276B2 (en) 2011-06-28 2015-02-03 Watson Laboratories, Inc. High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
EP3377490A1 (de) * 2015-11-16 2018-09-26 Fundacion para la Investigacion Medica Aplicada Neuartige verbindungen als inhibitoren von dna-methyltransferasen

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925320A (ja) * 1982-08-02 1984-02-09 Watanabe Yakuhin Kogyo Kk 薬物投与用貼付剤
EP0163696B1 (de) * 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Verwendung eines bioadhesives
EP0147780A3 (de) * 1984-01-03 1987-03-11 Merck & Co. Inc. Vorrichtung zur Freisetzung von Arzneistoffen
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
USD345211S (en) 1992-04-06 1994-03-15 Columbia Laboratories, Inc. Dispensing vial for feminine hygiene products
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
USD375352S (en) 1994-03-14 1996-11-05 Columbia Laboratories, Inc. Dispensing vial for feminine hygiene products
FR2720276B1 (fr) * 1994-05-24 1997-09-05 Christophe Boyer Nouvelle utilisation thérapeutique des agents bétamimétiques et médicament en contenant.
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
FR2725343B1 (fr) * 1994-10-10 1998-01-02 Jean Claude Attali Complexe insecticide et parasiticide, et procede de desinsectisation et de destruction des ectoparasites
US5985861A (en) 1996-11-04 1999-11-16 Columbia Laboratories, Inc. Progesterone for treating or reducing ischemia
EP0946197A1 (de) * 1996-11-29 1999-10-06 Monsanto Company Gleitfähiges formbeständiges (intaktes) gel zur oralen verabreichung biologosch aktiver stoffe
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
AU738460B2 (en) 2001-09-20
CN1270514A (zh) 2000-10-18
US20020012677A1 (en) 2002-01-31
EP1011632B1 (de) 2003-11-12
KR100575386B1 (ko) 2006-05-03
AU9131198A (en) 1999-04-05
JP2002503637A (ja) 2002-02-05
US6126959A (en) 2000-10-03
DE69819748D1 (de) 2003-12-18
CA2303339C (en) 2006-12-12
IL134564A0 (en) 2001-04-30
NO329203B1 (no) 2010-09-13
NO20001287L (no) 2000-03-10
EP1011632A2 (de) 2000-06-28
CN1186009C (zh) 2005-01-26
ATE253892T1 (de) 2003-11-15
KR20010030588A (ko) 2001-04-16
BR9812134A (pt) 2000-07-18
US6699494B2 (en) 2004-03-02
HUP0003784A2 (hu) 2001-08-28
HUP0003784A3 (en) 2001-12-28
WO1999013862A2 (en) 1999-03-25
DE69819748T2 (de) 2004-09-30
CA2303339A1 (en) 1999-03-25
NO20001287D0 (no) 2000-03-10
ES2210813T3 (es) 2004-07-01
NZ502926A (en) 2001-10-26
WO1999013862A3 (en) 1999-05-14
PT1011632E (pt) 2004-03-31
DK1011632T3 (da) 2004-03-29
RO120814B1 (ro) 2006-08-30

Similar Documents

Publication Publication Date Title
IL134564A0 (en) A pharmaceutical composition for treating dysmenorrhea and premature labor
MX9706449A (es) Composicion farmaceutica para compuestos de piperidinalcanol.
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
NZ332780A (en) Substituted amines for the treatment of neurological and neuropsychiatric disorders
ZA962536B (en) Pharmaceutical composition for transdermal administration.
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
CA2264901A1 (fr) Association inhibiteurs de no synthase et piegeurs des formes reactives de l'oxygene
EP0592569A4 (de) Zusammensetzung und verfahren zur transdermalen verabreichung von diclofenac.
AU6257798A (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
CA2270177A1 (en) Transdermal administration of ment
GB9212308D0 (en) Therapeutic compositions
SE9603725D0 (sv) New teatment
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
DE59609508D1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
EP0683668A4 (de) Präparate und verfahren für eine transdermale arzneistoffverabreichung.
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
GB9907571D0 (en) Compounds
PL348202A1 (en) Pharmaceutically active composition and dispensing device
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
IL126725A0 (en) Compositions comprising a nitrone compound for use in treating ocular inflammation
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
MY116275A (en) A pharmaceutical composition for treating dysmenorrhea and premature labor
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
PL328924A1 (en) Method of treating abuse of substances
ATE305795T1 (de) Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140908